Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth

View ORCID ProfileYi Li, Meng Liang, Xianhong Yin, Xiaoyu Liu, Meng Hao, Zixin Hu, Yi Wang, Li Jin
doi: https://doi.org/10.1101/2020.03.01.20029819
Yi Li
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
2Institute for Six-sector Economy, Fudan University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yi Li
Meng Liang
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianhong Yin
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoyu Liu
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meng Hao
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zixin Hu
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Wang
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lijin@fudan.edu.cn wangyi_fudan@fudan.edu.cn
Li Jin
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
2Institute for Six-sector Economy, Fudan University, Shanghai, China
3Institute of Data Sciences, Fudan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lijin@fudan.edu.cn wangyi_fudan@fudan.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Background In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China. Now the situation is almost controlled in China but is worse outside China. We aimed to build a mathematical model to capture the global trend of epidemics outside China.

Methods In this retrospective, outside-China diagnosis number reported from Jan 21 to Feb 28, 2020 was downloaded from WHO website. We develop a simple regression model on these numbers: Embedded Image where Nt is the total diagnosed patient till the ith day, t=1 at Feb 1.

Findings Based on this model, we estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China. The global trend is approximately exponential, with the rate of 10 folds every 19 days.

Evidence before this study In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China. Now the situation is almost controlled in China but is worse outside China. Now there are 4,691 patients across 51 countries and territories outside China. We searched PubMed and the China National Knowledge Infrastructure database for articles published up to Feb 28, 2020, using the keywords “COVID”, “novel coronavirus”, “2019-nCoV” or “2019 novel coronavirus”. No published work about the global trend of epidemics outside China could be identified.

Added value of this study We built a simple “log-plus” linear model to capture the global trend of epidemics outside China. We estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China. The global trend is approximately exponential, with the rate of 10 folds every 19 days.

Implications of all the available evidence With the limited number of data points and the complexity of the real situation, a straightforward model is expected to work better. Our model suggests that the COVID-19 disease follows an approximate exponential growth model stably at the very beginning. We predict that the number of confirmed patients outside China will increase ten folds in every 19 days without strong intervention by applying our model. Powerful actions on public health should be taken to combat this epidemic all over the world.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Daily diagnosis number of countries outside China is download from WHO situation reports (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports).

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth
Yi Li, Meng Liang, Xianhong Yin, Xiaoyu Liu, Meng Hao, Zixin Hu, Yi Wang, Li Jin
medRxiv 2020.03.01.20029819; doi: https://doi.org/10.1101/2020.03.01.20029819
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth
Yi Li, Meng Liang, Xianhong Yin, Xiaoyu Liu, Meng Hao, Zixin Hu, Yi Wang, Li Jin
medRxiv 2020.03.01.20029819; doi: https://doi.org/10.1101/2020.03.01.20029819

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)